First, we confirmed the expression levels of HER2 in breast cancer cells using Western blotting of cell lysates, demonstrating that only SKBR-3 and, to a much lesser extent, BT474 cells expressed HER2, whereas MCF-7 and MDA-MB-231 cells did not express HER2 (Fig. 3a). This evidence concerns the gene ERBB2 and breast cancer.